<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:jatt="http://jattacquisition.com/20260930"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="jatt-20260930.xsd" xlink:type="simple"/>
    <context id="cref_1429169508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_779805460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_642957339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_859701467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1545460942">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1640195479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_194219260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_649921143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">jatt:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_59993619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">jatt:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1795829695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-27</instant>
        </period>
    </context>
    <context id="cref_661148549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">jatt:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_514984852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">jatt:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_1793291393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jatt:WorkingCapitalLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_269893721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jatt:WorkingCapitalLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_612391333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jatt:PromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-03</startDate>
            <endDate>2026-09-03</endDate>
        </period>
    </context>
    <context id="cref_1911029236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jatt:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-09</instant>
        </period>
    </context>
    <context id="cref_2010596583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1535790496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jatt:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-25</startDate>
            <endDate>2026-08-25</endDate>
        </period>
    </context>
    <context id="cref_491329217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">jatt:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-25</startDate>
            <endDate>2026-08-25</endDate>
        </period>
    </context>
    <context id="cref_770046115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">jatt:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-25</instant>
        </period>
    </context>
    <context id="cref_1840998255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <instant>2026-08-25</instant>
        </period>
    </context>
    <context id="cref_710802102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">jatt:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_384336067">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-06</startDate>
            <endDate>2026-07-06</endDate>
        </period>
    </context>
    <context id="cref_1920795560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">jatt:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-06</startDate>
            <endDate>2026-07-06</endDate>
        </period>
    </context>
    <context id="cref_1133734158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <startDate>2026-07-06</startDate>
            <endDate>2026-07-06</endDate>
        </period>
    </context>
    <context id="cref_2101507198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jatt:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-09</startDate>
            <endDate>2026-06-09</endDate>
        </period>
    </context>
    <context id="cref_1685842102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jatt:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-09</startDate>
            <endDate>2026-06-09</endDate>
        </period>
    </context>
    <context id="cref_1790235815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_659250180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-27</instant>
        </period>
    </context>
    <context id="cref_540759954">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_1767713554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_738388019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jatt:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_1164252503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jatt:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_2139439115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jatt:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_1387117335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jatt:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_605365658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-27</instant>
        </period>
    </context>
    <context id="cref_937697158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_548625260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_486200464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jatt:TrustAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-27</instant>
        </period>
    </context>
    <context id="cref_1141314581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jatt:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-27</instant>
        </period>
    </context>
    <context id="cref_720375815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">jatt:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-27</instant>
        </period>
    </context>
    <context id="cref_155180102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">jatt:PublicSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_1012423201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_1139036627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-27</startDate>
            <endDate>2026-08-27</endDate>
        </period>
    </context>
    <context id="cref_327002114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jatt:JATTIIIAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-27</instant>
        </period>
    </context>
    <context id="cref_945300573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <instant>2026-08-27</instant>
        </period>
    </context>
    <context id="cref_424692103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-04-27</endDate>
        </period>
    </context>
    <context id="cref_308241727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_2052937114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1740510400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_888200052">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_788355583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_865243893">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_823487101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1390914283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_809689621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1484316918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1307034678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_699752073">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1823306478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1893480386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1903609617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <instant>2026-11-12</instant>
        </period>
    </context>
    <context id="cref_261648770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_756450437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
        </entity>
        <period>
            <instant>2026-04-26</instant>
        </period>
    </context>
    <context id="cref_633660117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-26</instant>
        </period>
    </context>
    <context id="cref_860766118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-26</instant>
        </period>
    </context>
    <context id="cref_2999132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002145659</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-26</instant>
        </period>
    </context>
    <unit id="uref_642957339">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_265278387">
        <measure>shares</measure>
    </unit>
    <unit id="uref_196960270">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_1000569309">
        <measure>pure</measure>
    </unit>
    <unit id="uref_888854378">
        <measure>jatt:Segment</measure>
    </unit>
    <us-gaap:NetIncomeLoss
      contextRef="cref_699752073"
      id="fc_863358346"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_261648770"
      id="fc_261648770"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="cref_788355583"
      id="fc_1584366476"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="cref_1740510400"
      id="fc_1352996703"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_788355583"
      id="fc_867428207"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_888200052"
      id="fc_2007073884"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_756450437"
      id="fc_756450437"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:OtherShortTermBorrowings
      contextRef="cref_859701467"
      id="fc_15975229"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_859701467"
      id="fc_1999110392"
      unitRef="uref_265278387"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_859701467"
      id="fc_1508299392"
      unitRef="uref_265278387"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="cref_642957339"
      id="fc_508205913"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseTrustPreferredSecurities
      contextRef="cref_642957339"
      id="fc_1699656861"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_779805460" id="fc_57278125">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_859701467"
      id="fc_1219459395"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_859701467"
      id="fc_144504867"
      unitRef="uref_265278387"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_859701467"
      id="fc_606511859"
      unitRef="uref_265278387"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_859701467"
      id="fc_318942992"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_859701467"
      id="fc_1216709866"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_633660117"
      id="fc_633660117"
      unitRef="uref_265278387"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_633660117"
      id="fc_1911380442"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_860766118"
      id="fc_860766118"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_2999132"
      id="fc_2999132"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_756450437"
      id="fc_843958119"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1307034678"
      id="fc_292237393"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1823306478"
      id="fc_416054838"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <jatt:StockIssuedDuringPeriodOfValueSaleOfPrivatePlacementShares
      contextRef="cref_1740510400"
      id="fc_303693188"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <jatt:AdjustmentsToAdditionalPaidInCapitalAllocatedValueOfTransactionCostsToPrivatePlacementShares
      contextRef="cref_788355583"
      id="fc_1039386914"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <jatt:AdjustmentsToAdditionalPaidInCapitalAllocatedValueOfTransactionCostsToPrivatePlacementShares
      contextRef="cref_1740510400"
      id="fc_558016134"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <jatt:ThresholdNumberOfBusinessDaysToRedeemPublicSharesFromCombinationPeriod contextRef="cref_548625260" id="fc_517424642">P10Y</jatt:ThresholdNumberOfBusinessDaysToRedeemPublicSharesFromCombinationPeriod>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_788355583"
      id="fc_1877687445"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:NumberOfReportableSegments
      contextRef="cref_779805460"
      decimals="0"
      id="fc_888854378"
      unitRef="uref_888854378">1</us-gaap:NumberOfReportableSegments>
    <dei:AmendmentFlag contextRef="cref_779805460" id="ixv-2893">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="cref_779805460" id="ixv-2894">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_779805460" id="ixv-2895">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="cref_779805460" id="ixv-2896">0002145659</dei:EntityCentralIndexKey>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_859701467"
      id="fc_1734874051"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_859701467"
      id="fc_1451906267"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="cref_859701467"
      id="fc_227653730"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <us-gaap:OtherBorrowings
      contextRef="cref_859701467"
      id="fc_1991817904"
      unitRef="uref_642957339"
      xsi:nil="true"/>
    <dei:EntityTaxIdentificationNumber contextRef="cref_779805460" id="fc_994926473">00-0000000</dei:EntityTaxIdentificationNumber>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_642957339"
      id="fc_211968587"
      unitRef="uref_265278387"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="cref_779805460" id="ixv-3413">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_779805460" id="ixv-3414">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_779805460" id="ixv-3415">2026-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_779805460" id="ixv-3416">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_779805460" id="ixv-3417">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_779805460" id="ixv-3418">001-43461</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_779805460" id="ixv-3419">JATT III ACQUISITION CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_779805460" id="ixv-3420">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="cref_779805460" id="ixv-3421">153     Central Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_779805460" id="ixv-3422">C/O 56</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_779805460" id="ixv-3423">Westfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_779805460" id="ixv-3424">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_779805460" id="ixv-3425">07091</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_779805460" id="ixv-3426">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_779805460" id="ixv-3427">688-0364</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_779805460" id="ixv-3428">ordinary     shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_779805460" id="ixv-3429">JTTT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_779805460" id="ixv-3430">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_779805460" id="ixv-3431">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_779805460" id="ixv-3432">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_779805460" id="ixv-3433">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_779805460" id="ixv-3434">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_779805460" id="ixv-3435">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_779805460" id="ixv-3436">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_779805460" id="ixv-3437">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1903609617"
      decimals="0"
      id="ixv-3438"
      unitRef="uref_265278387">8859000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3439"
      unitRef="uref_642957339">1046019</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3440"
      unitRef="uref_642957339">137246</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3441"
      unitRef="uref_642957339">1183265</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3442"
      unitRef="uref_642957339">113753</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3443"
      unitRef="uref_642957339">69233988</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3444"
      unitRef="uref_642957339">70531006</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3445"
      unitRef="uref_642957339">58332</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3446"
      unitRef="uref_642957339">58332</us-gaap:LiabilitiesCurrent>
    <jatt:DeferredLegalFees
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3447"
      unitRef="uref_642957339">20352</jatt:DeferredLegalFees>
    <jatt:DeferredUnderwritingFeePayable
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3448"
      unitRef="uref_642957339">2070000</jatt:DeferredUnderwritingFeePayable>
    <us-gaap:Liabilities
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3449"
      unitRef="uref_642957339">2148684</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="cref_859701467"
      decimals="4"
      id="ixv-3450"
      unitRef="uref_196960270">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3451"
      unitRef="uref_265278387">6900000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_859701467"
      decimals="2"
      id="ixv-3452"
      unitRef="uref_196960270">10.03</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3453"
      unitRef="uref_642957339">69233988</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_859701467"
      decimals="4"
      id="ixv-3454"
      unitRef="uref_196960270">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3455"
      unitRef="uref_265278387">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_859701467"
      decimals="4"
      id="fc_1126804911"
      unitRef="uref_196960270">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_859701467"
      decimals="0"
      id="fc_1266767969"
      unitRef="uref_265278387">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_859701467"
      decimals="0"
      id="fc_829457212"
      unitRef="uref_265278387">1959000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_859701467"
      decimals="0"
      id="fc_1034478199"
      unitRef="uref_265278387">1959000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_859701467"
      decimals="0"
      id="fc_593697160"
      unitRef="uref_642957339">196</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3461"
      unitRef="uref_642957339">-851862</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3462"
      unitRef="uref_642957339">-851666</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3463"
      unitRef="uref_642957339">70531006</us-gaap:LiabilitiesAndStockholdersEquity>
    <jatt:OrdinarySharesSubjectToForfeiture
      contextRef="cref_1893480386"
      decimals="0"
      id="ixv-3465"
      unitRef="uref_265278387">225000</jatt:OrdinarySharesSubjectToForfeiture>
    <jatt:SharesNoLongerSubjectToForfeiture
      contextRef="cref_605365658"
      decimals="0"
      id="ixv-3466"
      unitRef="uref_265278387">225000</jatt:SharesNoLongerSubjectToForfeiture>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3467"
      unitRef="uref_642957339">209128</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3468"
      unitRef="uref_642957339">228287</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3469"
      unitRef="uref_642957339">38806</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3470"
      unitRef="uref_642957339">38806</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3471"
      unitRef="uref_642957339">-247934</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3472"
      unitRef="uref_642957339">-267093</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3473"
      unitRef="uref_642957339">233988</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3474"
      unitRef="uref_642957339">233988</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3475"
      unitRef="uref_642957339">233988</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3476"
      unitRef="uref_642957339">233988</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3477"
      unitRef="uref_642957339">-13946</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3478"
      unitRef="uref_642957339">-33105</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1387117335"
      decimals="0"
      id="ixv-3479"
      unitRef="uref_265278387">2550000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1387117335"
      decimals="0"
      id="ixv-3480"
      unitRef="uref_265278387">2550000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1164252503"
      decimals="0"
      id="ixv-3481"
      unitRef="uref_265278387">1503846</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1164252503"
      decimals="0"
      id="ixv-3482"
      unitRef="uref_265278387">1503846</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1387117335"
      decimals="2"
      id="ixv-3483"
      unitRef="uref_196960270">-0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1387117335"
      decimals="2"
      id="ixv-3484"
      unitRef="uref_196960270">-0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1164252503"
      decimals="2"
      id="ixv-3485"
      unitRef="uref_196960270">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1164252503"
      decimals="2"
      id="ixv-3486"
      unitRef="uref_196960270">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_2139439115"
      decimals="0"
      id="fc_975804377"
      unitRef="uref_265278387">1669630</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_2139439115"
      decimals="0"
      id="fc_762058410"
      unitRef="uref_265278387">1669630</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_738388019"
      decimals="0"
      id="fc_1785748108"
      unitRef="uref_265278387">1600038</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_738388019"
      decimals="0"
      id="fc_1114352049"
      unitRef="uref_265278387">1600038</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_2139439115"
      decimals="2"
      id="ixv-3491"
      unitRef="uref_196960270">-0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_2139439115"
      decimals="2"
      id="ixv-3492"
      unitRef="uref_196960270">-0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_738388019"
      decimals="2"
      id="ixv-3493"
      unitRef="uref_196960270">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_738388019"
      decimals="2"
      id="ixv-3494"
      unitRef="uref_196960270">-0.01</us-gaap:EarningsPerShareDiluted>
    <jatt:AggregateOrdinarySharesSubjectToForfeiture
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3496"
      unitRef="uref_265278387">225000</jatt:AggregateOrdinarySharesSubjectToForfeiture>
    <jatt:SharesNoLongerSubjectToForfeitures
      contextRef="cref_424692103"
      decimals="0"
      id="ixv-3497"
      unitRef="uref_265278387">225000</jatt:SharesNoLongerSubjectToForfeitures>
    <jatt:AggregateOrdinarySharesSubjectToForfeiture
      contextRef="cref_1133734158"
      decimals="0"
      id="ixv-3499"
      unitRef="uref_265278387">431250</jatt:AggregateOrdinarySharesSubjectToForfeiture>
    <jatt:NumberOfFounderShares
      contextRef="cref_1920795560"
      decimals="0"
      id="ixv-3500"
      unitRef="uref_265278387">1725000</jatt:NumberOfFounderShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1823306478"
      decimals="0"
      id="fc_724493953"
      unitRef="uref_265278387">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1823306478"
      decimals="0"
      id="fc_1823306478"
      unitRef="uref_642957339">173</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_699752073"
      decimals="0"
      id="fc_699752073"
      unitRef="uref_642957339">24827</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1484316918"
      decimals="0"
      id="fc_126390346"
      unitRef="uref_642957339">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1307034678"
      decimals="0"
      id="ixv-3505"
      unitRef="uref_642957339">-19159</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1484316918"
      decimals="0"
      id="ixv-3506"
      unitRef="uref_642957339">-19159</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_809689621"
      decimals="0"
      id="ixv-3507"
      unitRef="uref_265278387">1725000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_809689621"
      decimals="0"
      id="ixv-3508"
      unitRef="uref_642957339">173</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1390914283"
      decimals="0"
      id="ixv-3509"
      unitRef="uref_642957339">24827</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_823487101"
      decimals="0"
      id="ixv-3510"
      unitRef="uref_642957339">-19159</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_865243893"
      decimals="0"
      id="ixv-3511"
      unitRef="uref_642957339">5841</us-gaap:StockholdersEquity>
    <jatt:StockIssuedDuringPeriodOfSharesSaleOfPrivatePlacementShares
      contextRef="cref_788355583"
      decimals="0"
      id="ixv-3512"
      unitRef="uref_265278387">234000</jatt:StockIssuedDuringPeriodOfSharesSaleOfPrivatePlacementShares>
    <jatt:StockIssuedDuringPeriodOfValueSaleOfPrivatePlacementShares
      contextRef="cref_788355583"
      decimals="0"
      id="ixv-3513"
      unitRef="uref_642957339">23</jatt:StockIssuedDuringPeriodOfValueSaleOfPrivatePlacementShares>
    <jatt:StockIssuedDuringPeriodOfValueSaleOfPrivatePlacementShares
      contextRef="cref_888200052"
      decimals="0"
      id="ixv-3514"
      unitRef="uref_642957339">2339977</jatt:StockIssuedDuringPeriodOfValueSaleOfPrivatePlacementShares>
    <jatt:StockIssuedDuringPeriodOfValueSaleOfPrivatePlacementShares
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3515"
      unitRef="uref_642957339">2340000</jatt:StockIssuedDuringPeriodOfValueSaleOfPrivatePlacementShares>
    <jatt:AdjustmentsToAdditionalPaidInCapitalAllocatedValueOfTransactionCostsToPrivatePlacementShares
      contextRef="cref_888200052"
      decimals="0"
      id="ixv-3516"
      unitRef="uref_642957339">-13149</jatt:AdjustmentsToAdditionalPaidInCapitalAllocatedValueOfTransactionCostsToPrivatePlacementShares>
    <jatt:AdjustmentsToAdditionalPaidInCapitalAllocatedValueOfTransactionCostsToPrivatePlacementShares
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3517"
      unitRef="uref_642957339">-13149</jatt:AdjustmentsToAdditionalPaidInCapitalAllocatedValueOfTransactionCostsToPrivatePlacementShares>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_888200052"
      decimals="0"
      id="ixv-3518"
      unitRef="uref_642957339">2390461</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1740510400"
      decimals="0"
      id="ixv-3519"
      unitRef="uref_642957339">818757</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3520"
      unitRef="uref_642957339">3209218</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="cref_888200052"
      decimals="0"
      id="ixv-3521"
      unitRef="uref_642957339">38806</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3522"
      unitRef="uref_642957339">38806</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1740510400"
      decimals="0"
      id="ixv-3523"
      unitRef="uref_642957339">-13946</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3524"
      unitRef="uref_642957339">-13946</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_2052937114"
      decimals="0"
      id="ixv-3525"
      unitRef="uref_265278387">1959000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_2052937114"
      decimals="0"
      id="ixv-3526"
      unitRef="uref_642957339">196</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_308241727"
      decimals="0"
      id="ixv-3527"
      unitRef="uref_642957339">-851862</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3528"
      unitRef="uref_642957339">-851666</us-gaap:StockholdersEquity>
    <jatt:AggregateOrdinarySharesSubjectToForfeiture
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3530"
      unitRef="uref_265278387">225000</jatt:AggregateOrdinarySharesSubjectToForfeiture>
    <jatt:SharesNoLongerSubjectToForfeitures
      contextRef="cref_424692103"
      decimals="0"
      id="ixv-3531"
      unitRef="uref_265278387">225000</jatt:SharesNoLongerSubjectToForfeitures>
    <jatt:AggregateOrdinarySharesSubjectToForfeiture
      contextRef="cref_1133734158"
      decimals="0"
      id="ixv-3533"
      unitRef="uref_265278387">431250</jatt:AggregateOrdinarySharesSubjectToForfeiture>
    <jatt:NumberOfFounderShares
      contextRef="cref_1920795560"
      decimals="0"
      id="ixv-3534"
      unitRef="uref_265278387">1725000</jatt:NumberOfFounderShares>
    <us-gaap:NetIncomeLoss
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3535"
      unitRef="uref_642957339">-33105</us-gaap:NetIncomeLoss>
    <jatt:PaymentOfFormationGeneralAndAdministrativeExpensesThroughIssuanceOfOrdinaryShares
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3536"
      unitRef="uref_642957339">25000</jatt:PaymentOfFormationGeneralAndAdministrativeExpensesThroughIssuanceOfOrdinaryShares>
    <jatt:PaymentOfOperatingExpensesThroughPromissoryNoteRelatedParty
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3537"
      unitRef="uref_642957339">6744</jatt:PaymentOfOperatingExpensesThroughPromissoryNoteRelatedParty>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3538"
      unitRef="uref_642957339">38806</us-gaap:ShareBasedCompensation>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3539"
      unitRef="uref_642957339">233988</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3540"
      unitRef="uref_642957339">137246</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidInsurance
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3541"
      unitRef="uref_642957339">113753</us-gaap:IncreaseDecreaseInPrepaidInsurance>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3542"
      unitRef="uref_642957339">58332</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <jatt:IncreaseDecreaseInDeferredLegalFees
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3543"
      unitRef="uref_642957339">-20352</jatt:IncreaseDecreaseInDeferredLegalFees>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3544"
      unitRef="uref_642957339">-368858</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3545"
      unitRef="uref_642957339">69000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3546"
      unitRef="uref_642957339">-69000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <jatt:ProceedsFromSaleOfPublicSharesNetOfUnderwritingDiscountsPaid
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3547"
      unitRef="uref_642957339">68310000</jatt:ProceedsFromSaleOfPublicSharesNetOfUnderwritingDiscountsPaid>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3548"
      unitRef="uref_642957339">2340000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <jatt:ProceedsFromUnderwritersReimbursement
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3549"
      unitRef="uref_642957339">172500</jatt:ProceedsFromUnderwritersReimbursement>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3550"
      unitRef="uref_642957339">40623</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3551"
      unitRef="uref_642957339">367000</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3552"
      unitRef="uref_642957339">70414877</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3553"
      unitRef="uref_642957339">1046019</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3554"
      unitRef="uref_642957339">1046019</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <jatt:OfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3555"
      unitRef="uref_642957339">342000</jatt:OfferingCostsIncludedInAccruedOfferingCosts>
    <jatt:OfferingCostsPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3556"
      unitRef="uref_642957339">33879</jatt:OfferingCostsPaidThroughPromissoryNoteRelatedParty>
    <jatt:DeferredUnderwritingFeePayables
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3557"
      unitRef="uref_642957339">2070000</jatt:DeferredUnderwritingFeePayables>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_779805460" id="ixv-1635">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 1&#160;&#x2014;&#160;ORGANIZATION AND PLAN OF BUSINESS OPERATIONS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;JATT III Acquisition Corp (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Cayman Islands exempted company on April 27, 2026. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a &#x201c;Business Combination&#x201d;). The Company will have 24&#160;months from the closing of the initial public offering to complete the initial Business Combination (the &#x201c;Completion Window&#x201d;). The Company has not selected any specific business combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial Business Combination with the Company.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of September 30, 2026, the Company had not commenced any operations. All activity for the period from April 27, 2026 (inception) through September 30, 2026 relates to the Company&#x2019;s formation, the initial public offering (the &#x201c;Initial Public Offering&#x201d;), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on August 25, 2026. On August 27, 2026, the Company consummated the Initial Public Offering of 6,900,000 ordinary shares (the &#x201c;Public Shares&#x201d;), which includes the full exercise by the underwriter of its over-allotment option in the amount of 900,000 Public Shares, at $10.00 per Public Share, generating gross proceeds of $69,000,000. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 234,000 Private Placement Shares (each &#x201c;Private Placement Share&#x201d;, collectively the &#x201c;Private Placement Shares&#x201d;), in a private placement to the Company&#x2019;s sponsor, JATT Ventures III L.P. (the &#x201c;Sponsor&#x201d;), at a price of $10.00 per Private Placement Share, generating gross proceeds of $2,340,000. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Transaction costs amounted to $2,988,379, consisting of $517,500 of cash underwriting fee (net of $172,500 of underwriter&#x2019;s reimbursement) and $2,070,000 of deferred underwriting fee, which were allocated to the Public Shares, and $400,879 of other offering costs, which were allocated pro-rata between the Public Shares and Private Placement Shares. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The rules of Nasdaq require that the Company must complete one or more business combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. The Company anticipates structuring the initial Business Combination so that the post transaction company in which the public shareholders own shares will own or acquire 100% of the equity interests or assets of the target business or businesses. The Company may, however, structure the initial Business Combination such that the post transaction company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but the Company will only complete such Business Combination if the post transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act&#160;of&#160;1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company will be able to successfully effect a Business Combination. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Following the closing of the Initial Public Offering, on August 27, 2026, an amount of $69,000,000 ($10.00 per Public Share) from the net proceeds of the sale of the Public Shares and the Private Placement Shares was placed in the trust account (the &#x201c;Trust Account&#x201d;), located in the United States, with Odyssey Transfer and Trust Company acting as trustee, and will be held in cash or invested in U.S.&#160;government treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act, which invest only in direct U.S.&#160;government treasury obligations, as determined by the Company, until the earliest of (i)&#160;the completion of a Business Combination and (ii)&#160;the distribution of the funds in the Trust Account to the Company&#x2019;s shareholders, as described below. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company will provide the holders of the public shares (the &#x201c;Public Shareholders&#x201d;) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i)&#160;in connection with a general meeting called to approve the Business Combination or (ii)&#160;without a shareholder vote&#160;by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two&#160;business&#160;days prior to the consummation of the Business Combination (initially invested at $10.00 per Public Share), including interest (less taxes paid or payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, subject to certain limitations as described in the prospectus. The per-share amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note&#160;6). The Public Shares were recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section&#160;13 of the Securities Exchange&#160;Act&#160;of&#160;1934, as amended (the &#x201c;Exchange&#160;Act&#x201d;)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company&#x2019;s prior written consent. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Sponsor, officers, directors and advisors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i)&#160;waive their redemption rights with respect to the Founder Shares, Private Placement Shares and any Public Shares they may acquire during or after the Initial Public Offering in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines that it is desirable to facilitate the completion of the initial Business Combination; (ii)&#160;waive their redemption rights with respect to the Founder Shares, Private Placement Shares and any Public Shares they may acquire during or after the Initial Public Offering in connection with a shareholder vote to approve an amendment to the articles (A)&#160;to modify the substance or timing of the obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Completion Window or (B)&#160;with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity; (iii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Placement Shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from assets outside the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame and to liquidating distributions from assets outside the Trust Account; and (iv)&#160;vote any Founder Shares held by them, any Private Placement Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination. If the Company submits the initial Business Combination to the Public Shareholders for a vote, the Company will complete the initial Business Combination only if it is approved by an ordinary resolution under Cayman Islands law, being the affirmative vote of at least a majority of the holders of the shares present in person or by proxy and entitled to vote thereon at a general meeting of the Company. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company will have until (i)&#160;the period ending on the date that is 24&#160;months from the closing of the Initial Public Offering, or such earlier liquidation as the Company&#x2019;s board of directors may approve, in which the Company must complete an initial Business Combination or (ii)&#160;such other time period in which the Company must complete an initial Business Combination pursuant to an amendment to the Company&#x2019;s Amended and Restated Memorandum and Articles of Association. However, if the Company has not completed a Business Combination within the Completion Window, the Company will as promptly as reasonably possible but not more than &lt;span style="-sec-ix-hidden:fc_517424642;"&gt;ten&lt;/span&gt;&#160;business&#160;days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes paid or payable and up to $100,000 of interest to pay liquidation expenses), divided by the number of then issued and outstanding Public Shares, which redemption will constitute full and complete payment for the Public Shares and completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Completion Window. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Completion Window. The underwriter has agreed to waive its rights to its deferred underwriting commission (see Note&#160;6) held in the Trust Account in the event the Company does not complete a Business Combination within the Completion Window, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per share ($10.00). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company&#x2019;s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1)&#160;$10.00 per Public Share (2)&#160;the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, less taxes payable and up to $100,000 of interest to pay dissolution expenses, provided that this liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company&#x2019;s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act&#160;of&#160;1933, as amended (the &#x201c;Securities Act&#x201d;). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company&#x2019;s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. &lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_642957339" id="ixv-3558">2026-04-27</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_1767713554"
      decimals="0"
      id="ixv-3559"
      unitRef="uref_265278387">6900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_540759954"
      decimals="0"
      id="ixv-3560"
      unitRef="uref_265278387">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1795829695"
      decimals="2"
      id="ixv-3561"
      unitRef="uref_196960270">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1767713554"
      decimals="0"
      id="ixv-3562"
      unitRef="uref_642957339">69000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_1790235815"
      decimals="0"
      id="ixv-3563"
      unitRef="uref_265278387">234000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_659250180"
      decimals="2"
      id="ixv-3564"
      unitRef="uref_196960270">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1790235815"
      decimals="0"
      id="ixv-3565"
      unitRef="uref_642957339">2340000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <jatt:TransactionCosts
      contextRef="cref_548625260"
      decimals="0"
      id="ixv-3566"
      unitRef="uref_642957339">2988379</jatt:TransactionCosts>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="cref_548625260"
      decimals="0"
      id="ixv-3567"
      unitRef="uref_642957339">517500</us-gaap:PaymentsForUnderwritingExpense>
    <jatt:UnderwritersReimbursementNet
      contextRef="cref_945300573"
      decimals="0"
      id="ixv-3568"
      unitRef="uref_642957339">172500</jatt:UnderwritersReimbursementNet>
    <jatt:DeferredUnderwritingFee
      contextRef="cref_548625260"
      decimals="0"
      id="ixv-3569"
      unitRef="uref_642957339">2070000</jatt:DeferredUnderwritingFee>
    <us-gaap:NoninterestExpenseOfferingCost
      contextRef="cref_548625260"
      decimals="0"
      id="ixv-3570"
      unitRef="uref_642957339">400879</us-gaap:NoninterestExpenseOfferingCost>
    <jatt:PercentageOfAggregateFairMarketValueOfTrustAccount
      contextRef="cref_548625260"
      decimals="2"
      id="ixv-3571"
      unitRef="uref_1000569309">0.80</jatt:PercentageOfAggregateFairMarketValueOfTrustAccount>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="cref_327002114"
      decimals="2"
      id="ixv-3572"
      unitRef="uref_1000569309">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <jatt:PercentageOfBusinessAcquisitionPostTransaction
      contextRef="cref_548625260"
      decimals="2"
      id="ixv-3573"
      unitRef="uref_1000569309">1</jatt:PercentageOfBusinessAcquisitionPostTransaction>
    <jatt:PercentageOfBusinessAcquisitionPostTransaction
      contextRef="cref_1139036627"
      decimals="2"
      id="ixv-3574"
      unitRef="uref_1000569309">0.50</jatt:PercentageOfBusinessAcquisitionPostTransaction>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_155180102"
      decimals="0"
      id="ixv-3575"
      unitRef="uref_642957339">69000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_720375815"
      decimals="2"
      id="ixv-3576"
      unitRef="uref_196960270">10</us-gaap:SaleOfStockPricePerShare>
    <jatt:InvestmentsMaximumMaturityTerm contextRef="cref_1012423201" id="ixv-3577">P185D</jatt:InvestmentsMaximumMaturityTerm>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_720375815"
      decimals="2"
      id="ixv-3578"
      unitRef="uref_196960270">10</us-gaap:SharesIssuedPricePerShare>
    <jatt:MaximumNetInterestToPayDissolutionExpenses
      contextRef="cref_548625260"
      decimals="0"
      id="ixv-3579"
      unitRef="uref_642957339">100000</jatt:MaximumNetInterestToPayDissolutionExpenses>
    <jatt:MaximumRedemptionSharesPercentage
      contextRef="cref_548625260"
      decimals="2"
      id="ixv-3580"
      unitRef="uref_1000569309">0.20</jatt:MaximumRedemptionSharesPercentage>
    <jatt:BusinessCombinationSharesRedeemPercentage
      contextRef="cref_155180102"
      decimals="2"
      id="ixv-3581"
      unitRef="uref_1000569309">1</jatt:BusinessCombinationSharesRedeemPercentage>
    <jatt:BusinessCombinationSharesRedeemPercentage
      contextRef="cref_548625260"
      decimals="2"
      id="ixv-3582"
      unitRef="uref_1000569309">1</jatt:BusinessCombinationSharesRedeemPercentage>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="cref_720375815"
      decimals="0"
      id="ixv-3583"
      unitRef="uref_642957339">100000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1141314581"
      decimals="2"
      id="ixv-3584"
      unitRef="uref_196960270">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_486200464"
      decimals="2"
      id="ixv-3585"
      unitRef="uref_196960270">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1795829695"
      decimals="2"
      id="ixv-3586"
      unitRef="uref_196960270">10</us-gaap:SaleOfStockPricePerShare>
    <jatt:MaximumNetInterestToPayDissolutionExpenses
      contextRef="cref_548625260"
      decimals="0"
      id="ixv-3587"
      unitRef="uref_642957339">100000</jatt:MaximumNetInterestToPayDissolutionExpenses>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_779805460" id="ixv-1698">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE                                             2&#160;&#x2014;&#160;SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s prospectus for its Initial Public Offering as filed with the SEC on August 26, 2026, as well as the Company&#x2019;s Current Report on Form 8-K, as filed with the SEC on September 2, 2026. The interim results for the three months ended September 30, 2026 and for the period from April 27, 2026 (inception) through September 30, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Liquidity and Capital Resources&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of September 30, 2026, the Company had cash of $1,046,019 and working capital of $1,124,933. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but is not obligated to, loan the Company funds as may be required (the &#x201c;Working Capital Loans&#x201d;). If the Company completes a Business Combination, the Company would repay such loaned amounts at that time. Up to $1,500,000 of such Working Capital Loans may be converted into private placement shares upon consummation of the Business Combination at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of September 30, 2026, the Company had &lt;span style="-sec-ix-hidden:fc_1991817904;"&gt;no&lt;/span&gt; borrowings under the Working Capital Loans. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, &#x201c;Presentation of Financial Statements - Going Concern,&#x201d; the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. The Company has the Completion Window to complete the initial Business Combination. Management has determined that upon the consummation of the Initial Public Offering and the sale of the Private Placement Shares, the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the unaudited condensed financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;             &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,046,019 in cash and &lt;span style="-sec-ix-hidden:fc_227653730;"&gt;no&lt;/span&gt; cash equivalents as of September 30, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Investments Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of September 30, 2026, the assets held in the Trust Account, amounting to $69,233,988, were held in U.S. Treasury bills and cash. The Company classifies its U.S. Treasury bills and equivalent securities as held to maturity in accordance with ASC Topic 320, &#x201c;Investments - Debt Securities.&#x201d; Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying unaudited condensed balance sheet and adjusted for the amortization or accretion of premiums or discounts. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A, &#x201c;Expenses of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. Offering costs allocated to Public Shares were charged to temporary equity and offering costs allocated to Private Placement Shares were charged to shareholders&#x2019; deficit.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; FASB ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2026, there were &lt;span style="-sec-ix-hidden:fc_1734874051;"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_1451906267;"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the periods presented. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;              &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying amounts represented in the accompanying unaudited condensed balance sheet, primarily due to their short-term nature.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Share-Based Payment Arrangements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company accounts for share awards in accordance with FASB ASC 718, &#x201c;Compensation&#x2014;Stock Compensation,&#x201d; which requires that all equity awards be accounted for at their &#x201c;fair value.&#x201d; Fair value is measured on the grant date and is equal to the underlying value of the share. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (i.e., the occurrence of a Business Combination). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company&#x2019;s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Ordinary Shares Subject to Possible Redemption&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s unaudited condensed balance sheet. As of September 30, 2026, the ordinary shares subject to possible redemption reflected in the unaudited condensed balance sheet are reconciled in the following table:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;69,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,975,230&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Accretion of ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;3,209,218&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt;"&gt;Ordinary shares subject to possible redemption, September 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;69,233,988&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Loss Per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; Income and losses are shared pro rata to the shares. Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable ordinary shares is excluded from net loss per ordinary share as the redemption value approximates fair value.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Founder shares issued to the Sponsor were subject to forfeiture contingent upon the exercise of the over-allotment option. Under ASC 260, Earnings Per Share, contingently returnable shares are excluded from the calculation of basic net loss per ordinary share until the contingency is resolved, and are excluded from diluted net loss per ordinary share as their effect would be anti-dilutive. Upon the exercise of the over-allotment option on August 27, 2026, the forfeiture restriction lapsed, and the 225,000 founder shares no longer subject to forfeiture were included in the weighted-average shares outstanding for basic net loss per ordinary share from that date forward. Because the Company reported a net loss for the periods presented, all potentially dilutive securities were anti-dilutive and excluded from diluted net loss per ordinary share; accordingly, basic and diluted net loss per ordinary share are the same.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of September 30, 2026, the Company did &lt;span style="-sec-ix-hidden:fc_211968587;"&gt;not&lt;/span&gt; have any other dilutive securities and contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;              &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Three Months Ended&lt;br/&gt; September 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Period&lt;br/&gt; from April 27, 2026&lt;br/&gt; (Inception)Through&lt;br/&gt; September 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non-redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non-redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: left;"&gt;Basic and diluted net loss per ordinary share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left;"&gt;Allocation of net loss&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(8,428&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(5,518&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(16,040&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(17,065&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Basic and diluted weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,550,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,669,630&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,503,846&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,600,038&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt;"&gt;Basic and diluted net loss per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.00&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.00&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.01&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.01&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_779805460" id="ixv-1703">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s prospectus for its Initial Public Offering as filed with the SEC on August 26, 2026, as well as the Company&#x2019;s Current Report on Form 8-K, as filed with the SEC on September 2, 2026. The interim results for the three months ended September 30, 2026 and for the period from April 27, 2026 (inception) through September 30, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:LiquidationBasisOfAccountingPolicyTextBlock contextRef="cref_779805460" id="ixv-1714">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Liquidity and Capital Resources&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of September 30, 2026, the Company had cash of $1,046,019 and working capital of $1,124,933. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but is not obligated to, loan the Company funds as may be required (the &#x201c;Working Capital Loans&#x201d;). If the Company completes a Business Combination, the Company would repay such loaned amounts at that time. Up to $1,500,000 of such Working Capital Loans may be converted into private placement shares upon consummation of the Business Combination at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of September 30, 2026, the Company had &lt;span style="-sec-ix-hidden:fc_1991817904;"&gt;no&lt;/span&gt; borrowings under the Working Capital Loans. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, &#x201c;Presentation of Financial Statements - Going Concern,&#x201d; the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. The Company has the Completion Window to complete the initial Business Combination. Management has determined that upon the consummation of the Initial Public Offering and the sale of the Private Placement Shares, the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the unaudited condensed financial statements.&lt;/p&gt;</us-gaap:LiquidationBasisOfAccountingPolicyTextBlock>
    <us-gaap:Cash
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3588"
      unitRef="uref_642957339">1046019</us-gaap:Cash>
    <jatt:WorkingCapital
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3589"
      unitRef="uref_642957339">1124933</jatt:WorkingCapital>
    <jatt:WorkingCapitalLoans
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3590"
      unitRef="uref_642957339">1500000</jatt:WorkingCapitalLoans>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="cref_937697158"
      decimals="2"
      id="ixv-3591"
      unitRef="uref_196960270">10</us-gaap:BusinessAcquisitionSharePrice>
    <jatt:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="cref_779805460" id="ixv-1726">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</jatt:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_779805460" id="ixv-1758">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_779805460" id="ixv-1769">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,046,019 in cash and &lt;span style="-sec-ix-hidden:fc_227653730;"&gt;no&lt;/span&gt; cash equivalents as of September 30, 2026. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3592"
      unitRef="uref_642957339">1046019</us-gaap:Cash>
    <jatt:CashAndInvestmentsHeldInTrustAccountPolicyTextBlock contextRef="cref_779805460" id="ixv-1777">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Investments Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of September 30, 2026, the assets held in the Trust Account, amounting to $69,233,988, were held in U.S. Treasury bills and cash. The Company classifies its U.S. Treasury bills and equivalent securities as held to maturity in accordance with ASC Topic 320, &#x201c;Investments - Debt Securities.&#x201d; Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying unaudited condensed balance sheet and adjusted for the amortization or accretion of premiums or discounts. &lt;/p&gt;</jatt:CashAndInvestmentsHeldInTrustAccountPolicyTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3593"
      unitRef="uref_642957339">69233988</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_779805460" id="ixv-1784">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3594"
      unitRef="uref_642957339">250000</us-gaap:CashFDICInsuredAmount>
    <jatt:OfferingCostsPolicyTextBlock contextRef="cref_779805460" id="ixv-1791">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A, &#x201c;Expenses of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. Offering costs allocated to Public Shares were charged to temporary equity and offering costs allocated to Private Placement Shares were charged to shareholders&#x2019; deficit.&lt;/p&gt;</jatt:OfferingCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_779805460" id="ixv-1798">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; FASB ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2026, there were &lt;span style="-sec-ix-hidden:fc_1734874051;"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_1451906267;"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the periods presented. &lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3595"
      unitRef="uref_642957339">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_779805460" id="ixv-1828">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying amounts represented in the accompanying unaudited condensed balance sheet, primarily due to their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="cref_779805460" id="ixv-1835">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Share-Based Payment Arrangements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company accounts for share awards in accordance with FASB ASC 718, &#x201c;Compensation&#x2014;Stock Compensation,&#x201d; which requires that all equity awards be accounted for at their &#x201c;fair value.&#x201d; Fair value is measured on the grant date and is equal to the underlying value of the share. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (i.e., the occurrence of a Business Combination). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company&#x2019;s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="cref_779805460" id="ixv-1842">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Ordinary Shares Subject to Possible Redemption&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s unaudited condensed balance sheet. As of September 30, 2026, the ordinary shares subject to possible redemption reflected in the unaudited condensed balance sheet are reconciled in the following table:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;69,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,975,230&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Accretion of ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;3,209,218&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt;"&gt;Ordinary shares subject to possible redemption, September 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;69,233,988&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="cref_779805460" id="ixv-3596">As of September 30, 2026, the ordinary shares subject to possible redemption reflected in the unaudited condensed balance sheet are reconciled in the following table:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;69,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,975,230&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Accretion of ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;3,209,218&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt;"&gt;Ordinary shares subject to possible redemption, September 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;69,233,988&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3597"
      unitRef="uref_642957339">69000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3598"
      unitRef="uref_642957339">2975230</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3599"
      unitRef="uref_642957339">3209218</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3600"
      unitRef="uref_642957339">69233988</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_779805460" id="ixv-1891">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Loss Per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; Income and losses are shared pro rata to the shares. Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable ordinary shares is excluded from net loss per ordinary share as the redemption value approximates fair value.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Founder shares issued to the Sponsor were subject to forfeiture contingent upon the exercise of the over-allotment option. Under ASC 260, Earnings Per Share, contingently returnable shares are excluded from the calculation of basic net loss per ordinary share until the contingency is resolved, and are excluded from diluted net loss per ordinary share as their effect would be anti-dilutive. Upon the exercise of the over-allotment option on August 27, 2026, the forfeiture restriction lapsed, and the 225,000 founder shares no longer subject to forfeiture were included in the weighted-average shares outstanding for basic net loss per ordinary share from that date forward. Because the Company reported a net loss for the periods presented, all potentially dilutive securities were anti-dilutive and excluded from diluted net loss per ordinary share; accordingly, basic and diluted net loss per ordinary share are the same.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of September 30, 2026, the Company did &lt;span style="-sec-ix-hidden:fc_211968587;"&gt;not&lt;/span&gt; have any other dilutive securities and contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;              &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Three Months Ended&lt;br/&gt; September 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Period&lt;br/&gt; from April 27, 2026&lt;br/&gt; (Inception)Through&lt;br/&gt; September 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non-redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non-redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: left;"&gt;Basic and diluted net loss per ordinary share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left;"&gt;Allocation of net loss&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(8,428&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(5,518&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(16,040&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(17,065&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Basic and diluted weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,550,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,669,630&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,503,846&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,600,038&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt;"&gt;Basic and diluted net loss per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.00&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.00&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.01&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.01&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <jatt:NoLongerSubjectToForfeitureShares
      contextRef="cref_605365658"
      decimals="0"
      id="fc_605365658"
      unitRef="uref_265278387">225000</jatt:NoLongerSubjectToForfeitureShares>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_779805460" id="ixv-1922">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Three Months Ended&lt;br/&gt; September 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Period&lt;br/&gt; from April 27, 2026&lt;br/&gt; (Inception)Through&lt;br/&gt; September 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non-redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non-redeemable&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: left;"&gt;Basic and diluted net loss per ordinary share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left;"&gt;Allocation of net loss&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(8,428&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(5,518&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(16,040&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;(17,065&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Basic and diluted weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,550,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,669,630&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,503,846&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,600,038&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt;"&gt;Basic and diluted net loss per ordinary share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.00&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.00&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.01&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;(0.01&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1387117335"
      decimals="0"
      id="ixv-3602"
      unitRef="uref_642957339">-8428</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1387117335"
      decimals="0"
      id="ixv-3603"
      unitRef="uref_642957339">-8428</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_2139439115"
      decimals="0"
      id="ixv-3604"
      unitRef="uref_642957339">-5518</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_2139439115"
      decimals="0"
      id="ixv-3605"
      unitRef="uref_642957339">-5518</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1164252503"
      decimals="0"
      id="ixv-3606"
      unitRef="uref_642957339">-16040</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1164252503"
      decimals="0"
      id="ixv-3607"
      unitRef="uref_642957339">-16040</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_738388019"
      decimals="0"
      id="ixv-3608"
      unitRef="uref_642957339">-17065</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_738388019"
      decimals="0"
      id="ixv-3609"
      unitRef="uref_642957339">-17065</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1387117335"
      decimals="0"
      id="ixv-3610"
      unitRef="uref_265278387">2550000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1387117335"
      decimals="0"
      id="ixv-3611"
      unitRef="uref_265278387">2550000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_2139439115"
      decimals="0"
      id="ixv-3612"
      unitRef="uref_265278387">1669630</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_2139439115"
      decimals="0"
      id="ixv-3613"
      unitRef="uref_265278387">1669630</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1164252503"
      decimals="0"
      id="ixv-3614"
      unitRef="uref_265278387">1503846</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1164252503"
      decimals="0"
      id="ixv-3615"
      unitRef="uref_265278387">1503846</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_738388019"
      decimals="0"
      id="ixv-3616"
      unitRef="uref_265278387">1600038</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_738388019"
      decimals="0"
      id="ixv-3617"
      unitRef="uref_265278387">1600038</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1387117335"
      decimals="2"
      id="ixv-3618"
      unitRef="uref_196960270">-0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1387117335"
      decimals="2"
      id="ixv-3619"
      unitRef="uref_196960270">-0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_2139439115"
      decimals="2"
      id="ixv-3620"
      unitRef="uref_196960270">-0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_2139439115"
      decimals="2"
      id="ixv-3621"
      unitRef="uref_196960270">-0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1164252503"
      decimals="2"
      id="ixv-3622"
      unitRef="uref_196960270">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1164252503"
      decimals="2"
      id="ixv-3623"
      unitRef="uref_196960270">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_738388019"
      decimals="2"
      id="ixv-3624"
      unitRef="uref_196960270">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_738388019"
      decimals="2"
      id="ixv-3625"
      unitRef="uref_196960270">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_779805460" id="ixv-2064">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <jatt:InitialPublicOfferingDisclosureTextBlock contextRef="cref_779805460" id="ixv-2072">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 3&#160;&#x2014;&#160;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Pursuant to the Initial Public Offering on August 27, 2026, the Company sold 6,900,000 Public Shares, which includes the full exercise by the underwriter of its over-allotment option in the amount of 900,000 Public Shares, at a purchase price of $10.00 per Public Share. &lt;/p&gt;</jatt:InitialPublicOfferingDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_1767713554"
      decimals="0"
      id="ixv-3626"
      unitRef="uref_265278387">6900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_540759954"
      decimals="0"
      id="ixv-3627"
      unitRef="uref_265278387">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1795829695"
      decimals="2"
      id="ixv-3628"
      unitRef="uref_196960270">10</us-gaap:SharesIssuedPricePerShare>
    <jatt:PrivatePlacementTextBlock contextRef="cref_779805460" id="ixv-2078">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 4&#160;&#x2014;&#160;PRIVATE PLACEMENT&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 234,000 Private Placement Shares to the Sponsor at a price of $10.00 per Private Placement Share, generating gross proceeds of $2,340,000. &lt;/p&gt;</jatt:PrivatePlacementTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_1790235815"
      decimals="0"
      id="ixv-3629"
      unitRef="uref_265278387">234000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_659250180"
      decimals="2"
      id="ixv-3630"
      unitRef="uref_196960270">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1790235815"
      decimals="0"
      id="ixv-3631"
      unitRef="uref_642957339">2340000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_779805460" id="ixv-2100">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 5&#160;&#x2014;&#160;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Founder Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On June 9, 2026, Sponsor paid $25,000 to cover certain costs of the Company in consideration for 2,156,250 ordinary shares (the &#x201c;Founder Shares&#x201d;). On July 6, 2026, the Sponsor surrendered and forfeited 431,250 Founder Shares to the Company for no consideration, following which the Sponsor holds 1,725,000 Founder Shares. All share and per share data have been retrospectively presented. The Founder Shares include an aggregate of up to 225,000 shares that are subject to forfeiture depending on the extent to which the underwriter&#x2019;s over-allotment option is exercised, so that the number of Founder Shares will equal, on an as-converted basis, approximately 20% of the Company&#x2019;s issued and outstanding ordinary shares after the Initial Public Offering (assuming the Sponsor does not purchase any Public Shares in the Initial Public Offering and excluding the Private Placement Shares). On August 27, 2026, the underwriter exercised its over-allotment option in full as part of the closing of the Initial Public Offering, as such, the 225,000 Founder Shares are no longer subject to forfeiture. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On August 25, 2026, the Sponsor granted membership interests equivalent to an aggregate of 315,000 Founder Shares to the Company&#x2019;s officers, directors, and advisor in exchange for their respective professional services to the Company throughout the Company&#x2019;s initial Business Combination. The Founder Shares will remain with the Sponsor if the holders of the Founder Shares are no longer serving the Company prior to the initial Business Combination. The assignment of the Founder Shares to the holders of such interests are in the scope of FASB ASC Topic 718, &#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under FASB ASC 718, stock-based compensation associated with equity classified awards is measured at fair value upon the assignment date. The total fair value of the 315,000 Founder Shares on August 25, 2026 was $759,780 or $2.412 per share. The Company established the initial fair value of the Founder Shares on August 25, 2026, the date of the grant agreement, using Monte Carlo Simulation Model prepared by a third-party valuation team which takes into consideration the underlying share price of $10.00 and implied market adjustment of 24.1%. Share-based compensation shall be subject to straight-line monthly vesting over the course of 24 months from the date when the registration statement of the Initial Public Offering became effective, provided that the holder continues to work for the Company as an officer, director or advisor. If the holder is an officer, director or advisor of the Company immediately prior to the consummation of a Business Combination, any unvested share interests owned by the holder will vest in full on consummation of the Business Combination. Any share interest that is not vested when a holder ceases to work as an officer, director or advisor to the Company shall be forfeited and cancelled unless the Sponsor decides otherwise, whereby the Sponsor shall make the decision that such share interests shall not be forfeited and cancelled. As of September 30, 2026, the Company recognized stock-based compensation expense of $38,806 and will continue to recognize such expense over the course of 24 months from the effectivity of the Initial Public Offering registration statement. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of (A)&#160;180 days after the completion of a Business Combination&#160;and (B)&#160;the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Public Shares for cash, securities or other property. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Administrative Services Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company entered into an agreement, commencing on August 25, 2026 through the earlier of the Company&#x2019;s consummation of a Business Combination and its liquidation, to pay the Sponsor or its affiliates, a total of $20,000 per month for officer compensation and administrative services. For the three months ended September 30, 2026 and for the period from April 27, 2026 (inception) through September 30, 2026, the Company incurred $24,516 in fees under this agreement, of which $4,516 is included in accounts payable and accrued expenses in the accompanying unaudited condensed balance sheet. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the closing of the Company&#x2019;s Initial Public Offering, the Company&#x2019;s Chief Financial Officer (&#x201c;CFO&#x201d;) received compensation from the Sponsor consisting of a one-time, lump-sum payment of $35,714 for services rendered in connection with the Initial Public Offering. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Promissory Note &#x2014; Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On June 9, 2026, the Sponsor entered into an agreement to loan the Company an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing, unsecured and due at the earlier of December 31, 2026 or the closing of the Initial Public Offering. The Company had borrowed $40,623 under the promissory note which was fully repaid subsequent to the closing of the Initial Public Offering on September 3, 2026. Borrowings under the promissory note are no longer available. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Related Party Loans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into Private Placement Shares of the post-Business Combination entity at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of September 30, 2026, the Company had &lt;span style="-sec-ix-hidden:fc_15975229;"&gt;no&lt;/span&gt; outstanding borrowings under the Working Capital Loans. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <jatt:SponsorPaidCost
      contextRef="cref_1685842102"
      decimals="0"
      id="fc_1685842102"
      unitRef="uref_642957339">25000</jatt:SponsorPaidCost>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_2101507198"
      decimals="0"
      id="fc_2101507198"
      unitRef="uref_265278387">2156250</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <jatt:AggregateOrdinarySharesSubjectToForfeiture
      contextRef="cref_1133734158"
      decimals="0"
      id="ixv-3634"
      unitRef="uref_265278387">431250</jatt:AggregateOrdinarySharesSubjectToForfeiture>
    <jatt:NumberOfFounderShares
      contextRef="cref_1920795560"
      decimals="0"
      id="ixv-3635"
      unitRef="uref_265278387">1725000</jatt:NumberOfFounderShares>
    <jatt:AggregateOrdinarySharesSubjectToForfeiture
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3636"
      unitRef="uref_265278387">225000</jatt:AggregateOrdinarySharesSubjectToForfeiture>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="cref_384336067"
      decimals="2"
      id="ixv-3637"
      unitRef="uref_1000569309">0.20</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="cref_710802102"
      decimals="0"
      id="ixv-3638"
      unitRef="uref_265278387">225000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="cref_491329217"
      decimals="0"
      id="ixv-3639"
      unitRef="uref_265278387">315000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <jatt:FairValueOfFounderShare
      contextRef="cref_1840998255"
      decimals="0"
      id="ixv-3640"
      unitRef="uref_265278387">315000</jatt:FairValueOfFounderShare>
    <jatt:FairValueOfFounderSharesValue
      contextRef="cref_1840998255"
      decimals="0"
      id="ixv-3641"
      unitRef="uref_642957339">759780</jatt:FairValueOfFounderSharesValue>
    <jatt:FairValueOfFounderShares
      contextRef="cref_1840998255"
      decimals="3"
      id="ixv-3642"
      unitRef="uref_196960270">2.412</jatt:FairValueOfFounderShares>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_770046115"
      decimals="2"
      id="ixv-3643"
      unitRef="uref_196960270">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction
      contextRef="cref_491329217"
      decimals="3"
      id="ixv-3644"
      unitRef="uref_1000569309">0.241</us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="cref_491329217" id="ixv-3645">P24M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3646"
      unitRef="uref_642957339">38806</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="cref_642957339" id="ixv-3647">P24M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <jatt:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences contextRef="cref_642957339" id="ixv-3648">P180D</jatt:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_1535790496"
      decimals="0"
      id="ixv-3649"
      unitRef="uref_642957339">20000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3650"
      unitRef="uref_642957339">24516</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3651"
      unitRef="uref_642957339">24516</us-gaap:AdministrativeFeesExpense>
    <us-gaap:PaymentsForFees
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3652"
      unitRef="uref_642957339">4516</us-gaap:PaymentsForFees>
    <jatt:PaymentsForServices
      contextRef="cref_2010596583"
      decimals="0"
      id="ixv-3653"
      unitRef="uref_642957339">35714</jatt:PaymentsForServices>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_1911029236"
      decimals="0"
      id="ixv-3654"
      unitRef="uref_642957339">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_612391333"
      decimals="0"
      id="ixv-3655"
      unitRef="uref_642957339">40623</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="cref_269893721"
      decimals="0"
      id="ixv-3656"
      unitRef="uref_642957339">1500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="cref_1793291393"
      decimals="2"
      id="ixv-3657"
      unitRef="uref_196960270">10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_779805460" id="ixv-2162">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 6&#160;&#x2014;&#160;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Registration Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The holders of the Founder Shares, Private Placement Shares and any shares that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant to a registration and shareholder rights agreement signed on August 25, 2026. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company&#x2019;s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Underwriting Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company granted the underwriter a 45-day option to purchase up to 900,000 additional Public Shares to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On August 27, 2026, the underwriter elected to fully exercise its over-allotment option to purchase an additional 900,000 Public Shares at a price of $10.00 per Public Share. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The underwriter was entitled to a cash underwriting discount of $0.10 per Public Share, or $690,000 in the aggregate, which was paid upon the closing of the Initial Public Offering. The underwriter paid the Company an aggregate amount of $172,500 at the closing of the Initial Public Offering as reimbursement to the Company for certain of its expenses and fees incurred in connection with the Initial Public Offering. In addition, the underwriter was entitled to a deferred fee of $0.30 per share, or $2,070,000 in the aggregate. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. At the Company&#x2019;s sole and absolute discretion, up to $327,500 of this amount may be paid to third parties not participating in the Initial Public Offering that assist the Company in consummating its initial Business Combination. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Deferred Legal Fees&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of September 30, 2026, the Company had $20,352 of deferred legal fees incurred to be paid to the Company&#x2019;s legal advisor upon consummation of the Business Combination. The deferred legal fees are classified as a non-current liability in the accompanying unaudited condensed balance sheet.&#160; &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <jatt:UnderwriterDayOption contextRef="cref_642957339" id="ixv-3658">P45D</jatt:UnderwriterDayOption>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_514984852"
      decimals="0"
      id="ixv-3659"
      unitRef="uref_265278387">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_661148549"
      decimals="0"
      id="ixv-3660"
      unitRef="uref_265278387">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1795829695"
      decimals="2"
      id="ixv-3661"
      unitRef="uref_196960270">10</us-gaap:SaleOfStockPricePerShare>
    <jatt:CashUnderwritingDiscountPerShare
      contextRef="cref_642957339"
      decimals="2"
      id="ixv-3662"
      unitRef="uref_196960270">0.1</jatt:CashUnderwritingDiscountPerShare>
    <jatt:CashUnderwritingDiscount
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3663"
      unitRef="uref_642957339">690000</jatt:CashUnderwritingDiscount>
    <jatt:DeferredUnderwritingFeePayable
      contextRef="cref_59993619"
      decimals="0"
      id="fc_59993619"
      unitRef="uref_642957339">172500</jatt:DeferredUnderwritingFeePayable>
    <jatt:DeferredFeePerShare
      contextRef="cref_642957339"
      decimals="2"
      id="ixv-3665"
      unitRef="uref_196960270">0.3</jatt:DeferredFeePerShare>
    <jatt:DeferredUnderwritingFeePayable
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3666"
      unitRef="uref_642957339">2070000</jatt:DeferredUnderwritingFeePayable>
    <jatt:CompanysSoleAndAbsoluteDiscretionAmount
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3667"
      unitRef="uref_642957339">327500</jatt:CompanysSoleAndAbsoluteDiscretionAmount>
    <jatt:DeferredLegalFees
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3668"
      unitRef="uref_642957339">20352</jatt:DeferredLegalFees>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_779805460" id="ixv-2207">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 7&#160;&#x2014;&#160;SHAREHOLDERS&#x2019; DEFICIT&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preference Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001&#160;per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. As of September 30, 2026, there were &lt;span style="-sec-ix-hidden:fc_1999110392;"&gt;&lt;span style="-sec-ix-hidden:fc_1508299392;"&gt;no&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Ordinary Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue 200,000,000 ordinary shares, with a par value of $0.0001 per share. As of September 30, 2026, there were 1,959,000 ordinary shares issued and outstanding, which includes 1,725,000 Founder Shares, 234,000 Private Placement Shares, and excludes 6,900,000 shares that are subject to possible redemption. The Founder Shares will automatically convert into ordinary shares at the time of a Business Combination or earlier at the option of the holders. &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3669"
      unitRef="uref_265278387">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_859701467"
      decimals="4"
      id="ixv-3670"
      unitRef="uref_196960270">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3671"
      unitRef="uref_265278387">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_859701467"
      decimals="4"
      id="ixv-3672"
      unitRef="uref_196960270">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3673"
      unitRef="uref_265278387">1959000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3674"
      unitRef="uref_265278387">1959000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_649921143"
      decimals="0"
      id="ixv-3675"
      unitRef="uref_265278387">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <jatt:StockIssuedDuringPeriodOfSharesSaleOfPrivatePlacementShares
      contextRef="cref_194219260"
      decimals="0"
      id="ixv-3676"
      unitRef="uref_265278387">234000</jatt:StockIssuedDuringPeriodOfSharesSaleOfPrivatePlacementShares>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3677"
      unitRef="uref_265278387">6900000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_779805460" id="ixv-2224">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 8 &#x2014; FAIR VALUE MEASUREMENTS&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in; text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.5in; text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level 1:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in; text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.5in; text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level 2:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in; text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.5in; text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level 3:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Unobservable inputs based on the Company&#x2019;s assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; At September 30, 2026, assets held in the Trust Account were comprised of $144 in cash and $69,233,844 in U.S. Treasury bills. For the period from April 27, 2026 (inception) through September 30, 2026, the Company did &lt;span style="-sec-ix-hidden:fc_1699656861;"&gt;not&lt;/span&gt; withdraw any interest income from the Trust Account. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table presents information about the gross holding loss and fair value of held-to-maturity U.S Treasury bills at September 30, 2026:&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify;"&gt;Held-To-Maturity&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Level&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Amortized&lt;br/&gt; Cost&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Gross&lt;br/&gt; Holding&lt;br/&gt; Loss&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="vertical-align: top; width: 20%; text-align: left; padding-bottom: 2.5pt;"&gt;September 30, 2026&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 31%; text-align: left; padding-bottom: 2.5pt;"&gt;U.S. Treasury Bills (Mature on 11/27/2026)&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: center;"&gt;1&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right;"&gt;69,233,844&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right;"&gt;(42,317&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right;"&gt;69,191,527&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3678"
      unitRef="uref_642957339">144</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3679"
      unitRef="uref_642957339">69233844</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="cref_779805460" id="ixv-2261">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table presents information about the gross holding loss and fair value of held-to-maturity U.S Treasury bills at September 30, 2026:&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify;"&gt;Held-To-Maturity&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Level&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Amortized&lt;br/&gt; Cost&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Gross&lt;br/&gt; Holding&lt;br/&gt; Loss&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="vertical-align: top; width: 20%; text-align: left; padding-bottom: 2.5pt;"&gt;September 30, 2026&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 31%; text-align: left; padding-bottom: 2.5pt;"&gt;U.S. Treasury Bills (Mature on 11/27/2026)&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: center;"&gt;1&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right;"&gt;69,233,844&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right;"&gt;(42,317&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right;"&gt;69,191,527&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:HeldtomaturitySecuritiesDebtMaturitiesDate contextRef="cref_1640195479" id="ixv-3680">2026-11-27</us-gaap:HeldtomaturitySecuritiesDebtMaturitiesDate>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="cref_1545460942"
      decimals="0"
      id="ixv-3681"
      unitRef="uref_642957339">69233844</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="cref_1545460942"
      decimals="0"
      id="ixv-3682"
      unitRef="uref_642957339">42317</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="cref_1545460942"
      decimals="0"
      id="ixv-3683"
      unitRef="uref_642957339">69191527</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_779805460" id="ixv-2306">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE&#160;9 &#x2014;&#160;SEGMENT INFORMATION&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;FASB ASC Topic&#160;280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), or group, in deciding how to allocate resources and assess performance.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s CODM has been identified as the &lt;span style="-sec-ix-hidden:fc_57278125;"&gt;Chief Executive Officer&lt;/span&gt;, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has &lt;span style="-sec-ix-hidden:fc_888854378;"&gt;one&lt;/span&gt; reporting segment. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed statements of operations as net income or loss. The measure of segment assets is reported on the unaudited condensed balance sheet as total assets. When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in the total assets, which include the following:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;September 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%;"&gt;Cash&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,046,019&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;69,233,988&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Three Months Ended&lt;br/&gt;  September 30, &lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Period from April 27,&lt;br/&gt;  2026 (Inception) through&lt;br/&gt;  September 30, &lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Formation, general and administrative costs&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;209,128&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;228,287&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Share-based compensation expense&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;38,806&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;38,806&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Interest earned on cash and investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;233,988&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;233,988&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The CODM reviews the position of total assets to assess if the Company has sufficient resources available to discharge its liabilities. The CODM is provided with details of cash and liquid resources available with the Company. The CODM will review the interest that will be earned and accrued on cash held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Formation, general and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Completion Window. The CODM also reviews formation, general and administrative costs and share-based compensation expense to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Formation, general and administrative costs and share-based compensation expense as reported on the accompanying unaudited condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_779805460" id="ixv-2314">The Company&#x2019;s CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="cref_779805460" id="ixv-3684">When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in the total assets, which include the following: &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;September 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%;"&gt;Cash&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,046,019&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;69,233,988&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Three Months Ended&lt;br/&gt;  September 30, &lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;For the Period from April 27,&lt;br/&gt;  2026 (Inception) through&lt;br/&gt;  September 30, &lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Formation, general and administrative costs&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;209,128&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;228,287&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Share-based compensation expense&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;38,806&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;38,806&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Interest earned on cash and investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;233,988&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;233,988&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Cash
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3685"
      unitRef="uref_642957339">1046019</us-gaap:Cash>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_859701467"
      decimals="0"
      id="ixv-3686"
      unitRef="uref_642957339">69233988</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3687"
      unitRef="uref_642957339">209128</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3688"
      unitRef="uref_642957339">228287</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3689"
      unitRef="uref_642957339">38806</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3690"
      unitRef="uref_642957339">38806</us-gaap:ShareBasedCompensation>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1429169508"
      decimals="0"
      id="ixv-3691"
      unitRef="uref_642957339">233988</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_642957339"
      decimals="0"
      id="ixv-3692"
      unitRef="uref_642957339">233988</us-gaap:InvestmentIncomeInterest>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_779805460" id="ixv-2413">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 10&#160;&#x2014;&#160;SUBSEQUENT EVENTS&lt;/span&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_1429169508" id="ixv-3693">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_1429169508" id="ixv-3694">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_1429169508" id="ixv-3695">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_1429169508" id="ixv-3696">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_1266767969"
          xlink:label="fc_1266767969"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_593697160"
          xlink:label="fc_593697160"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_829457212"
          xlink:label="fc_829457212"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1034478199"
          xlink:label="fc_1034478199"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1126804911"
          xlink:label="fc_1126804911"
          xlink:type="locator"/>
        <link:footnote id="fref_1475044733" xlink:label="fref_1475044733" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Up to 225,000 ordinary shares were formerly subject to forfeiture depending on the extent to which the underwriter&#x2019;s over-allotment option was exercised. On August 27, 2026, the underwriter exercised its over-allotment option in full as part of the closing of the Initial Public Offering, as such, the 225,000 ordinary shares are no longer subject to forfeiture (Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1266767969"
          xlink:to="fref_1475044733"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_593697160"
          xlink:to="fref_1475044733"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_829457212"
          xlink:to="fref_1475044733"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1034478199"
          xlink:to="fref_1475044733"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1126804911"
          xlink:to="fref_1475044733"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_724493953"
          xlink:label="fc_724493953"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1823306478"
          xlink:label="fc_1823306478"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_292237393"
          xlink:label="fc_292237393"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_126390346"
          xlink:label="fc_126390346"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_699752073"
          xlink:label="fc_699752073"
          xlink:type="locator"/>
        <link:footnote id="fref_1335787356" xlink:label="fref_1335787356" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes an aggregate of     up to 225,000 ordinary shares that were subject to forfeiture depending on the extent to which the underwriter&#x2019;s over-allotment     option was exercised (Note&#160;5). On August 27, 2026, the underwriter exercised its over-allotment option in full as part of the     closing of the Initial Public Offering, as such, the 225,000 ordinary shares are no longer subject to forfeiture (Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_724493953"
          xlink:to="fref_1335787356"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1823306478"
          xlink:to="fref_1335787356"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_292237393"
          xlink:to="fref_1335787356"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_126390346"
          xlink:to="fref_1335787356"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_699752073"
          xlink:to="fref_1335787356"
          xlink:type="arc"/>
        <link:footnote id="fref_1595344546" xlink:label="fref_1595344546" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On July 6, 2026, the Sponsor surrendered and forfeited 431,250 Founder Shares to the Company for no consideration, following which the Sponsor holds 1,725,000 Founder Shares. All share and per share data have been retrospectively presented.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_724493953"
          xlink:to="fref_1595344546"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1823306478"
          xlink:to="fref_1595344546"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_292237393"
          xlink:to="fref_1595344546"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_126390346"
          xlink:to="fref_1595344546"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_699752073"
          xlink:to="fref_1595344546"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1785748108"
          xlink:label="fc_1785748108"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_975804377"
          xlink:label="fc_975804377"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1114352049"
          xlink:label="fc_1114352049"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_762058410"
          xlink:label="fc_762058410"
          xlink:type="locator"/>
        <link:footnote id="fref_864655429" xlink:label="fref_864655429" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes an aggregate of up to 225,000 ordinary shares that were subject to forfeiture depending on the extent to which the underwriter&#x2019;s over-allotment option was exercised (Note&#160;5). On August 27, 2026, the underwriter exercised its over-allotment option in full as part of the closing of the Initial Public Offering, as such, the 225,000 ordinary shares are no longer subject to forfeiture (Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1785748108"
          xlink:to="fref_864655429"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_975804377"
          xlink:to="fref_864655429"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1114352049"
          xlink:to="fref_864655429"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_762058410"
          xlink:to="fref_864655429"
          xlink:type="arc"/>
        <link:footnote id="fref_97296880" xlink:label="fref_97296880" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On July 6, 2026, the Sponsor surrendered and forfeited 431,250 Founder Shares to the Company for no consideration, following which the Sponsor holds 1,725,000 Founder Shares. All share and per share data have been retrospectively presented.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1785748108"
          xlink:to="fref_97296880"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_975804377"
          xlink:to="fref_97296880"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1114352049"
          xlink:to="fref_97296880"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_762058410"
          xlink:to="fref_97296880"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
